Literature DB >> 6341140

Residual B cell function in diabetic children as determined by urinary C-peptide.

J Aurbach-Klipper, R Sharph-Dor, L G Heding, M Karp, Z Laron.   

Abstract

C-peptide was determined in 24-h urine collections and in fasting plasma of 27 Type 1 (insulin-dependent) diabetic children (duration of disease 0-6 years) and in 11 matched normal children. Grouping the patients according to duration of disease from onset to 6 years, it was found that in the first year of disease the B cell reserve was a mean of 4.89 +/- 1.95 pmol X mg creatinine-1. 24 h-1 compared with a mean of 24.51 +/- 2.91 pmol X mg-1 X 24 h-1 in the control group. A further diminution was seen with increase in the duration of disease, until after 6 years when only traces of C-peptide could be detected. There was a good correlation between the levels of plasma C-peptide and urinary C-peptide values as related to creatinine (r = 0.89; p = less than 0.001). In view of this, and since it is simpler and less traumatic to obtain frequent urine samples from children than it is to obtain blood samples, it was felt that the determination of urinary C-peptide constitutes a valuable tool in the evaluation of the diabetic child.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341140     DOI: 10.1007/bf00297387

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  C-peptide immunoreactivity (CPR) in urine.

Authors:  T Kuzuya; A Matsuda; Y Sakamoto; S Tanabshi; H Kajinuma
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

2.  Residual beta-cell function and islet cell antibodies in diabetic children.

Authors:  J R Crossley; A G James; R B Elliot; C C Berryman; B W Edgar
Journal:  Pediatr Res       Date:  1981-01       Impact factor: 3.756

3.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

4.  Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine.

Authors:  D L Horwitz; A H Rubenstein; A I Katz
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

5.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  HLA-types, C-peptide and insulin antibodies in juvenile diabetes.

Authors:  J Ludvigsson; J Säfwenberg; L G Heding
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

7.  Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity.

Authors:  L A Grajwer; R S Pildes; D L Horwitz; A H Rubenstein
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

8.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03

9.  Urine C-peptide, beta-cell function, and insulin requirement.

Authors:  E B Rappaport; R A Ulstrom; D D Etzwiler; D Fife; B E Hedlund; M W Steffes
Journal:  Am J Dis Child       Date:  1980-12

10.  Kinetics of human C-peptide in man.

Authors:  O K Faber; H Kehlet; S Madsbad; C Binder
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

View more
  4 in total

1.  Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics.

Authors:  C Giordano; A Galluzzo; F Pantò; C Caruso; G Bompiani
Journal:  Acta Diabetol Lat       Date:  1987 Oct-Dec

2.  Residual insulin secretion in insulin dependent diabetes mellitus.

Authors:  S Rogers; M Silink
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

3.  Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Authors:  Rachel E J Besser; Johnny Ludvigsson; Angus G Jones; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02-01       Impact factor: 19.112

4.  Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.

Authors:  H J Yoo; S G Hartling; C Binder
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.